Critical Updates to Regulatory Requirements for Injectable Packaging

The December 2025 implementation of USP <382> marks the most consequential regulatory change to functional suitability requirements for elastomeric container closure components in injectable drug packaging since the original USP <381> framework — and pharmaceutical teams that have not yet initiated qualification activities under the new standard face significant time pressure. This on-demand webinar, presented by Datwyler's Manager of Regulatory Affairs and active contributor to Ph.Eur. Expert Group 16, ISO TC76/WG4, and PDA Task Force on TR 73-2, delivers a section-by-section technical briefing on USP <382> alongside updates to the broader global regulatory landscape for injectable packaging. The webinar opens with a review of why <382> was necessary — identifying the gap between component-level testing under the current <381> and the system-level performance evidence required to demonstrate fitness for intended use across the diversity of vial, syringe, cartridge, pen injector, and BFS delivery systems in modern pharmaceutical pipelines. The full <382> test program is then covered in detail: section 4 (system integrity testing per USP <1207> with maximum allowable leakage limit acceptance criteria); section 5 (needle and spike access requirements — fragmentation with ≥150 µm fragment count, penetration force, needle self-sealing capacity using in-use system integrity concepts, and spike retention and sealability); section 6 (plunger functional suitability — break-loose and extrusion forces on filled systems with no quantitative acceptance criteria, and plunger seal integrity procedures A through D for manual syringes, non-manual/auto-injector systems, dental cartridges, and other cartridge formats); and section 7 (tip cap and needle shield axial pull-off and torque removal forces). The session also addresses the Chinese Pharmacopoeia 2020 and 2025 editions, EU GMP Annex 1 scope for primary packaging materials, EU MDR requirements for combination products with device components, and the full packaging specifications framework spanning USP <381>, <382>, <1663>, <1664>, <233>, and related chapters.